Back to search

Spain· ES:08489002

OPGENRA 3,3 mg POLVO PARA SUSPENSION PARA IMPLANTACION

A medicinal product containing eptotermina alfa, registered in Spain by Olympus Biotech International Limited.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedOPGENRA 3,3 mg POLVO PARA SUSPENSION …ATC—REGISTER NO.ES:08489002PACKS LISTED0CHECKEDJune 3, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
eptotermina alfa
Manufacturer
Olympus Biotech International Limited
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Eptotermina alfa in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eptotermina alfa products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3e1ea212-07da-42b4-891e-b1ab8257a333
GET /v1/drugs/3e1ea212-07da-42b4-891e-b1ab8257a333?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1311890400000,\"rev\":1733928725000}",
  "nregistro": "08489002",
  "substance": "eptotermina alfa"
}

See everything about eptotermina alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.